RSS

Texas Medical Center and Johnson & Johnson announce new incubator

Johnson & Johnson Innovation, LLC., has announced plans to expand J-Labs (formally called Janssen Labs) to include a new incubator located within Texas Medical Center’s new Innovation Institute.

This facility is located at 2450 Holcombe Boulevard, Houston, Texas. The 30,000-square foot J-Labs facility will accommodate up to 50 life science startups.

“As one of the top five global biotechnology clusters, and home to the Texas Medical Center, the largest medical center in the world, Houston is a flourishing life science hub in which we see great potential for an incubator to enable the talented scientists in the region to take their innovation to the next level,” said Melinda Richter, head of J-Labs, part of Johnson & Johnson Innovation.

“The continued demand for our J-Labs model fueled our decision to expand with J-Labs @TMC, which furthers our goal of helping entrepreneurs advance science with the potential to become transformational solutions for patients.”

Johnson & Johnson Innovation seeks to find the best science and technology, no matter where it is, to solve the greatest unmet needs of our time. J-Labs @TMC will link regional entrepreneurs with the full breadth of Johnson & Johnson Innovation including funding, services and education with direct access to R&D expertise from our medical device and diagnostic technologies, consumer healthcare products, and Janssen pharmaceuticals teams.

J-Labs @TMC will also follow the same no-strings attached approach currently in operation at the California- and Boston- based J-Labs facilities.

“The arrival of J-Labs @TMC creates a resource-rich environment that will not only support new startups fueled by the numerous medical and research institutes in the region, but will also be attractive to investors and entrepreneurs in the strong Texas life science industry. We look forward to launching the life science incubator in our space with J-Labs and supporting their efforts to help bring innovation in the region to market,” said Robert C. Robbins, president and chief executive officer of the Texas Medical Center.